The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

11226–11250 of 17785

  • SevereFDA (Drugs)·D-0201-2017·2016-12-21

    Cantrell Drug Company Recalls Oxytocin Injection Bags Due to Sterility Concerns

    Cantrell Drug Company is recalling 2,681 bags of Oxytocin 30 USP Units due to a lack of assurance of sterility. The affected product is distributed nationwide.

    Product
    Oxytocin 30 USP Units Added to 0.9% Sodium Chloride, 500 mL Bag, Single-Dose Bag, Injection Solution for IV Use Only, Rx Only, Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-056-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0197-2017·2016-12-21

    Cantrell Drug Recalls Lidocaine HCl Syringes Due to Sterility Concerns

    Cantrell Drug Company is recalling 162 syringes of Lidocaine HCl 1% because the firm cannot assure the sterility of the product.

    Product
    Lidocaine HCl 1%, 10 mL Syringe, Hospital/Office Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Rd. Little Rock, AR 72207
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0196-2017·2016-12-21

    Cantrell Drug Recalls Hydromorphone Injection Vials Due to Sterility Concerns

    Cantrell Drug Company is recalling 93 vials of Hydromorphone HCl injection solution nationwide due to a lack of assurance of sterility.

    Product
    Hydromorphone HCl 1 mg/mL in 0.9% Sodium Chloride 30 mL PCA Vial (1 mg/mL), Single-Dose Injection Solution For Slow IV Use, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-006-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0186-2017·2016-12-21

    Cantrell Drug Company Recalls Calcium Chloride Bags Due to Sterility Concerns

    Cantrell Drug Company is recalling 73 bags of Calcium Chloride in 0.9% Sodium Chloride due to a lack of assurance of sterility.

    Product
    Calcium Chloride (20 mg/mL) in 0.9% Sodium Chloride 500 mL Bag, Rx Only, Single-Dose Bag Cantrell Drug Company 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-102-09
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0204-2017·2016-12-21

    Cantrell Recalls Succinylcholine Chloride Injection Due to Sterility Concerns

    Cantrell Drug Company is recalling specific lots of Succinylcholine Chloride 200 mg/10 mL injection syringes because the firm cannot ensure the products are sterile.

    Product
    Succinylcholine Chloride 200 mg/10 mL Injection Solution 10 mL (20 mg/mL) ,Single-Dose Syringe Injection Solution, For Slow IV Use Only ,Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207, NDC 52533-067-12
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0203-2017·2016-12-21

    Cantrell Drug Recalls Ropivacaine HCl Bags Due to Sterility Concerns

    Cantrell Drug Company is recalling 87 bags of Ropivacaine HCl 0.25% due to a lack of assurance of sterility. The product is intended for epidural use only.

    Product
    Ropivacaine HCl 0.25% in 0.9% Sodium Chloride, 100 mL Bag, Epidural Use Only, Rx Only, Cantrell Drug Co. 7321 Cantrell Road Little Rock, AR 72207, NDC 52533-185-75
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0205-2017·2016-12-21

    Jubilant Cadista Recalls Methylprednisolone Tablets Due to Incorrect Expiration Date Labeling

    Jubilant Cadista Pharmaceuticals is recalling 1,512 bottles of Methylprednisolone Tablets, USP, 16 mg, because the expiration date is printed incorrectly as 02/0218 instead of 02/2018.

    Product
    Methylprednisolone Tablets, USP, 16 mg, 50-count bottles, Rx only, Manufactured by Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-003-14.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-0174-2017·2016-12-14

    Fallon Wellness Pharmacy Recalls PAPA/PHEN/PROST Injection Due to Sterility Concerns

    Fallon Wellness Pharmacy is recalling 5 vials of PAPA/PHEN/PROST injection due to environmental monitoring excursions that raise concerns about sterility assurance.

    Product
    PAPA/PHEN/PROST (papverine/phentolamine/prostaglandin) 30 mg/4 mg/0.04 mg/mL Injection, 1 mL vials, Fallon Wellness Pharmacy LLC, 1057 Troy-Schenectady Rd, Latham, NY 12110.
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0173-2017·2016-12-14

    Fallon Wellness Pharmacy Recalls Papaverine Injection Due to Sterility Concerns

    Fallon Wellness Pharmacy is recalling 10 vials of PAPA/PHEN/PROST injection due to environmental monitoring excursions that raise concerns about sterility assurance.

    Product
    PAPA/PHEN/PROST (papverine/phentolamine/prostaglandin) 18 mg/0.6 mg/0.006 mg/mL Injection, 1 mL vials, Fallon Wellness Pharmacy LLC, 1057 Troy-Schenectady Rd, Latham, NY 12110.
    Category
    Drug
    Distribution
    1 state
  • LowFDA (Drugs)·D-0171-2017·2016-12-14

    Teva Recalls Qnasl Nasal Aerosol Due to Content Uniformity Failure

    Teva Pharmaceuticals USA is recalling Qnasl nasal aerosol because stability testing showed the product failed content uniformity specifications.

    Product
    Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0170-2017·2016-12-14

    Teva Recalls Qnasl Nasal Aerosol Due to Content Uniformity Failure

    Teva Pharmaceuticals is recalling Qnasl nasal aerosol canisters because the product failed stability testing for spray content uniformity.

    Product
    Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0172-2017·2016-12-14

    West-Ward Recalls Sodium Ferric Gluconate Injection Due to Low Iron Content

    West-Ward Pharmaceuticals is recalling 5,142 shelf-packs of Sodium Ferric Gluconate Complex in Sucrose Injection because stability testing revealed the product had lower iron content than specified.

    Product
    SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE — SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE (SODIUM FERRIC GLUCONATE COMPLEX IN SUCROSE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0169-2017·2016-12-14

    Hospira Recalls Lidocaine and Dextrose Injection for Stability Failures

    Hospira Inc. is recalling specific lots of 5% Lidocaine HCL and 7.5% Dextrose Injection because they failed stability specifications for color and pH.

    Product
    5% Lidocaine HCL and 7.5% Dextrose Injection, USP, 2 mL Single-dose ampule, 5 count box, Rx Only, For Spinal Anesthesia Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-4712-01
    Category
    Drug
    Distribution
    1 state
  • SevereFDA (Drugs)·D-0164-2017·2016-12-07

    Cadila Pharmaceuticals Recalls Microbially Contaminated Ondansetron HCI API

    Cadila Pharmaceuticals is recalling bulk Ondansetron HCI API due to microbial contamination. The affected product was distributed to two US consignees.

    Product
    Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 393002
    Category
    Drug
    Distribution
    0 states
  • HighFDA (Drugs)·D-0154-2017·2016-12-07

    Par Pharmaceutical Recalls Travoprost Ophthalmic Solution Due to Sterility Concerns

    Par Pharmaceutical is recalling specific lots of Travoprost Ophthalmic Solution because the dropper tips may be damaged, compromising sterility.

    Product
    Travoprost Ophthalmic Solution USP, 0.004%, a) 2.5 mL and b) 5 mL bottles, Rx only, FOR USE IN THE EYES ONLY, Made in India, Distributed by: Par Pharmaceutical Cos., Inc, Spring Valley, NY 10977
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0156-2017·2016-12-07

    Burel Pharmaceuticals Recalls UROLET MB Tablets Due to Manufacturing Deficiencies

    Burel Pharmaceuticals is recalling UROLET MB Urinary Antiseptic tablets because manufacturing deficiencies may cause the product to fail potency or uniformity tests.

    Product
    UROLET MB URINARY ANTISEPTIC, ANTISPASMODIC Tablets, Each tablet contains: Methenamine 81.6 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue, 10.8 mg; Hyoscyamine Sulfate, 0.12 mg, (a) 30 count (NDC 35573-302-30) and (b) 100 count bottles (NDC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0159-2017·2016-12-07

    Burel Pharmaceuticals Recalls AZUPHEN MB Urinary Antiseptic Capsules

    Burel Pharmaceuticals is recalling AZUPHEN MB Urinary Antiseptic Capsules due to manufacturing deviations that may cause assay or content uniformity failures.

    Product
    AZUPHEN MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 120 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0162-2017·2016-12-07

    Burel Pharmaceuticals Recalls Phenazopyridine Hydrochloride Tablets Due to Manufacturing Deficiencies

    Burel Pharmaceuticals is recalling specific lots of Phenazopyridine Hydrochloride Tablets due to manufacturing deviations that may result in assay or content uniformity failures.

    Product
    Phenazopyridine Hydrochloride Tablets, USP, 200 mg, 100 count bottles, Rx only, Manufactured for: Burel Pharmaceuticals, Inc., Richland, MS --- NDC 35573-306-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0166-2017·2016-12-07

    Nationwide Laboratories Recalls Salsalate Tablets Due to Manufacturing Deviations

    Nationwide Laboratories is recalling Salsalate Tablets, 750 mg, because they were manufactured under practices that may result in assay or content uniformity failures.

    Product
    Salsalate Tablets, USP, 750 mg, packaged in a) 100 count bottles (NDC 42937-704-10); b) 500 count bottles (NDC 42937-704-18); and c) 1000 count bottles (NDC 42937-704-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0167-2017·2016-12-07

    Nationwide Laboratories Recalls Phenazopyridine Hydrochloride Tablets Due to Manufacturing Deviations

    Nationwide Laboratories is recalling Phenazopyridine Hydrochloride Tablets due to manufacturing deviations that may result in assay or content uniformity failures.

    Product
    Phenazopyridine Hydrochloride Tablets, USP, 100 mg, 100 count bottles, Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830, NDC 42937-701-10.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0165-2017·2016-12-07

    Nationwide Laboratories Recalls Salsalate Tablets Due to Manufacturing Deviations

    Nationwide Laboratories is recalling Salsalate Tablets, USP, 500 mg, because they were manufactured under practices that may result in assay or content uniformity failures.

    Product
    Salsalate Tablets, USP, 500 mg, packaged in a) 500 count bottles (NDC 42937-703-18); b) 100 count bottles (NDC 42937-703-10); and c) 1000 count bottles (NDC 42937-703-20); Rx only, Manufactured for: Nationwide Laboratories LLC, Iselin, New Jersey 08830.
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0155-2017·2016-12-07

    Burel Recalls Hyolev MB Urinary Antiseptic Tablets Due to Manufacturing Deficiencies

    Burel Pharmaceuticals is recalling 2,861 bottles of Hyolev MB Urinary Antiseptic Tablets due to manufacturing deviations that may cause assay or content uniformity failures.

    Product
    Hyolev MB URINARY ANTISEPTIC Tablets, Each tablet for oral administration contains: Hyoscyamine Sulfate 0.12 mg, Methenamine 81 mg, Methylene Blue 10.8 mg, Phenyl Salicylate 32.4 mg, Sodium Phosphate Monobasic 40.8 mg, 90 count bottles, Rx only, Manufactured for: BUREL…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0158-2017·2016-12-07

    Burel Pharmaceuticals Recalls UROPHEN MB Urinary Antiseptic Tablets

    Burel Pharmaceuticals is recalling UROPHEN MB Urinary Antiseptic Tablets due to manufacturing deviations that may cause assay or content uniformity failures.

    Product
    UROPHEN MB URINARY ANTISEPTIC Tablets, Each tablet contains: Methenamine 81.6 mg, Benzoic Acid 9.0 mg, Phenyl Salicylate 36 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC…
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0157-2017·2016-12-07

    Burel Pharmaceuticals Recalls Uramit MB Urinary Antiseptic Capsules

    Burel Pharmaceuticals is recalling Uramit MB Urinary Antiseptic Capsules due to manufacturing deviations that may cause assay or content uniformity failures.

    Product
    URAMIT MB URINARY ANTISEPTIC Capsules, Each capsule contains: Methenamine 118 mg, Monobasic Sodium Phosphate 40.8 mg, Phenyl Salicylate 36 mg, Methylene Blue 10 mg, Hyoscyamine Sulfate, 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS…
    Category
    Drug
    Distribution
    Distributed nationwide